-Search query
-Search result
Showing 1 - 50 of 358 items for (author: dai & at)
EMDB-37390:
Cryo-EM structure of peptide free and Gs-coupled GIPR
Method: single particle / : Cong ZT, Zhao FH, Li Y, Luo G, Zhou QT, Yang DH, Wang MW, Dai AT, Shen DD, Zhang Y, Xia T, Stevens RC, Xu HE, Zhao LH
EMDB-28752:
Cryo-electron tomography of wild type a-synuclein preformed fibrils
Method: electron tomography / : Jiang J, Boparai N, Dai W, Kim YS
EMDB-28753:
Cryo-electron tomography of S42Y a-synuclein preformed fibrils
Method: electron tomography / : Jiang J, Boparai N, Dai W, Kim YS
EMDB-36326:
Cryo-EM structure of the GLP-1R/GCGR dual agonist peptide15-bound human GLP-1R-Gs complex
Method: single particle / : Yang L, Zhou QT, Dai AT, Zhao FH, Chang RL, Ying TL, Wu BL, Yang DH, Wang MW, Cong ZT
EMDB-41066:
Human VMAT2 in complex with tetrabenazine
Method: single particle / : Pidathala S, Dai Y, Lee CH
EMDB-41067:
Human VMAT2 in complex with reserpine
Method: single particle / : Pidathala S, Dai Y, Lee CH
EMDB-41068:
Human VMAT2 in complex with serotonin
Method: single particle / : Pidathala S, Dai Y, Lee CH
PDB-8t69:
Human VMAT2 in complex with tetrabenazine
Method: single particle / : Pidathala S, Dai Y, Lee CH
PDB-8t6a:
Human VMAT2 in complex with reserpine
Method: single particle / : Pidathala S, Dai Y, Lee CH
PDB-8t6b:
Human VMAT2 in complex with serotonin
Method: single particle / : Pidathala S, Dai Y, Lee CH
EMDB-34741:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-34742:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 focused on RBD and NIV-11 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
PDB-8hgl:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
PDB-8hgm:
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-35706:
Cryo-EM structure of GIPR splice variant 1 (SV1) in complex with Gs protein
Method: single particle / : Zhao FH, Hang KN, Zhou QT, Shao LJ, Li H, Li WZ, Lin S, Dai AT, Cai XQ, Liu YY, Xu YN, Feng WB, Yang DH, Wang MW
EMDB-35707:
Cryo-EM structure of GIPR splice variant 2 (SV2) in complex with Gs protein
Method: single particle / : Zhao FH, Hang KN, Zhou QT, Shao LJ, Li H, Li WZ, Lin S, Dai AT, Cai XQ, Liu YY, Xu YN, Feng WB, Yang DH, Wang MW
EMDB-29530:
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-29531:
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-40240:
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8fxb:
SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8fxc:
SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
PDB-8s9g:
SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab fragment
Method: single particle / : Park YJ, Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
EMDB-35601:
Cryo-EM structure of the alpha-MSH-bound human melanocortin receptor 5 (MC5R)-Gs complex
Method: single particle / : Feng WB, Zhou QT, Chen XY, Dai AT, Cai XQ, Liu X, Zhao FH, Chen Y, Ye CY, Xu YN, Cong ZT, Li H, Lin S, Yang DH, Wang MW
EMDB-35615:
Cryo-EM structure of the gamma-MSH-bound human melanocortin receptor 3 (MC3R)-Gs complex
Method: single particle / : Feng WB, Zhou QT, Chen XY, Dai AT, Cai XQ, Liu X, Zhao FH, Chen Y, Ye CY, Xu YN, Cong ZT, Li H, Lin S
EMDB-35616:
Cryo-EM structure of the PG-901-bound human melanocortin receptor 5 (MC5R)-Gs complex
Method: single particle / : Feng WB, Zhou QT, Chen XY, Dai AT, Cai XQ, Liu X, Zhao FH, Chen Y, Ye CY, Xu YN, Cong ZT, Li H, Lin S, Yang DH, Wang MW
EMDB-36324:
Cryo-EM structure of the GLP-1R/GCGR dual agonist Peptide 15-bound human GCGR-Gs complex
Method: single particle / : Yang L, Zhou QT, Dai AT, Zhao FH, Chang RL, Ying TL, Wu BL, Yang DH, Wang MW, Cong ZT
EMDB-36328:
Cryo-EM structure of the GLP-1R/GCGR dual agonist SAR425899-bound human GCGR-Gs complex
Method: single particle / : Yang L, Zhou QT, Dai AT, Zhao FH, Chang RL, Ying TL, Wu BL, Yang DH, Wang MW, Cong ZT
EMDB-36323:
Cryo-EM structure of the GLP-1R/GCGR dual agonist MEDI0382-bound human GLP-1R-Gs complex
Method: single particle / : Yang L, Zhou QT, Dai AT, Zhao FH, Chang RL, Ying TL, Wu BL, Yang DH, Wang MW, Cong ZT
EMDB-36325:
Cryo-EM structure of the GLP-1R/GCGR dual agonist SAR425899-bound human GLP-1R-Gs complex
Method: single particle / : Yang L, Zhou QT, Dai AT, Zhao FH, Chang RL, Ying TL, Wu BL, Yang DH, Wang MW, Cong ZT
EMDB-36327:
Cryo-EM structure of the GLP-1R/GCGR dual agonist MEDI0382-bound human GCGR-Gs complex
Method: single particle / : Yang L, Zhou QT, Dai AT, Zhao FH, Chang RL, Ying TL, Wu BL, Yang DH, Wang MW, Cong ZT
EMDB-40305:
Cryo-EM structure of insulin amyloid-like fibril that is composed of two antiparallel protofilaments
Method: single particle / : Wang LW, Hall C, Uchikawa E, Chen DL, Choi E, Zhang XW, Bai XC
PDB-8sbd:
Cryo-EM structure of insulin amyloid-like fibril that is composed of two antiparallel protofilaments
Method: single particle / : Wang LW, Hall C, Uchikawa E, Chen DL, Choi E, Zhang XW, Bai XC
EMDB-33820:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 focused on RBD and NIV-8 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33821:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33822:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33823:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 focused on RBD and NIV-10 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33824:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33825:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33826:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33827:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 focused on RBD and NIV-13 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33828:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33829:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-33830:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
PDB-7yh6:
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-8
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
PDB-7yh7:
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y
EMDB-29374:
Structure of SARS-CoV2 spike protein
Method: single particle / : Mou Z, Tan TJC, Lei R, Wu NC, Dai X
EMDB-35399:
Structure of human alpha-2/delta-1 with mirogabalin
Method: single particle / : Kozai D, Numoto N, Fujiyoshi Y
EMDB-35400:
Structure of human alpha-2/delta-1 without mirogabalin
Method: single particle / : Kozai D, Numoto N, Fujiyoshi Y
PDB-8if3:
Structure of human alpha-2/delta-1 with mirogabalin
Method: single particle / : Kozai D, Numoto N, Fujiyoshi Y
PDB-8if4:
Structure of human alpha-2/delta-1 without mirogabalin
Method: single particle / : Kozai D, Numoto N, Fujiyoshi Y
Pages: